Richards, Merrill & Peterson, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 7 shares of HRMY stock, worth $272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$272% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
45.6MCall Options Held
111KPut Options Held
46.9K-
Valor Management LLC Chicago, IL6.62MShares$258 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$227 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$185 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$61.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...